- Home
- CMPX vs BRT Comparison
CMPX vs BRT Comparison
Compare CMPX & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- BRT
- Stock Information
- Founded
- CMPX 2014
- BRT 1972
- Country
- CMPX United States
- BRT United States
- Employees
- CMPX N/A
- BRT N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- BRT Real Estate Investment Trusts
- Sector
- CMPX Health Care
- BRT Real Estate
- Exchange
- CMPX Nasdaq
- BRT Nasdaq
- Market Cap
- CMPX 408.6M
- BRT 331.7M
- IPO Year
- CMPX N/A
- BRT N/A
- Fundamental
- Price
- CMPX $1.95
- BRT $16.98
- Analyst Decision
- CMPX Strong Buy
- BRT Strong Buy
- Analyst Count
- CMPX 7
- BRT 3
- Target Price
- CMPX $12.43
- BRT $21.83
- AVG Volume (30 Days)
- CMPX 850.8K
- BRT 28.7K
- Earning Date
- CMPX 05-12-2025
- BRT 03-12-2025
- Dividend Yield
- CMPX N/A
- BRT 5.89%
- EPS Growth
- CMPX N/A
- BRT N/A
- EPS
- CMPX N/A
- BRT N/A
- Revenue
- CMPX $850,000.00
- BRT $97,274,000.00
- Revenue This Year
- CMPX $47.65
- BRT $5.43
- Revenue Next Year
- CMPX $3,909.48
- BRT $5.39
- P/E Ratio
- CMPX N/A
- BRT N/A
- Revenue Growth
- CMPX N/A
- BRT 1.65
- 52 Week Low
- CMPX $0.77
- BRT $15.92
- 52 Week High
- CMPX $4.08
- BRT $20.22
- Technical
- Relative Strength Index (RSI)
- CMPX 31.88
- BRT 37.06
- Support Level
- CMPX $2.18
- BRT $17.75
- Resistance Level
- CMPX $2.17
- BRT $18.37
- Average True Range (ATR)
- CMPX 0.16
- BRT 0.62
- MACD
- CMPX -0.03
- BRT -0.11
- Stochastic Oscillator
- CMPX 14.60
- BRT 0.00
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is primarily focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.